drugset / Trial / NCT02588807
Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the safety of combining phospholipids with medicinal plants for treatment of patients with amyotrophic lateral sclerosis (ALS)
Timeline
- Start
- 2021-01-01
- Primary completion
- 2021-09
- Completion
- 2022-05
Outcome
Outcome not reported
Stopped: “The sponsor and hospital did not reach agreement”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Spirit1 | Unknown | — | — |